Millions of lives are lost worldwide every year due to AIDS, tuberculosis and malaria, constituting a major obstacle to growth in developing countries. Africa suffers from a particularly severe shortage of health care providers, which hinders the provision of health care services to overcome such diseases.
Antenatal and postnatal care are suitable entry points for the critical expansion of disease prevention, screening and treatment. However, the delivery of the recommended interventions during antenatal care, including screening, diagnosis and management of infectious diseases, remains below global targets.
Takeda has supported the Global Fund since 2010, making it the longest corporate partnership to date and an exemplary model of private sector engagement. Its financial support has helped strengthen the capacity of health workers in Kenya, Nigeria and Tanzania, and build resilient and sustainable health systems, a key strategic objective of the Global Fund.
Takeda’s first pledge of JP¥ 1 billion (approximately US$10 million) for 2010-2019 helped boost malaria prevention efforts in Tanzania with the distribution of mosquito nets; accelerated access to TB treatment in Kenya; and expanded HIV services and awareness in Nigeria.
In 2019, Takeda became the first private sector company to announce a financial commitment to the Global Fund’s Sixth Replenishment, pledging an additional JP¥ 1 billion over five years. This investment is intended to support the improvement of maternal and child health by integrating quality HIV, tuberculosis and malaria services in antenatal and postnatal care in several priority countries in Africa.